Reference |
17846
Sasanuma H, Tsuda M, Morimoto S, Saha LK, Rahman MM, Kiyooka Y, Fujiike H, Cherniack AD, Itou J, Callen Moreu E, Toi M, Nakada S, Tanaka H, Tsutsui K, Yamada S, Nussenzweig A, Takeda S.
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes
Proc Natl Acad Sci U S A
2018
115(45):E10642-E10651
PubMed ID: 30352856
DOI: 10.1073/pnas.1803177115
|
17839
Hoa NN, Shimizu T, Zhou ZW, Wang ZQ, Deshpande RA, Paull TT, Akter S, Tsuda M, Furuta R, Tsutsui K, Takeda S, Sasanuma H.
Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes
Mol Cell
2016
64(3):580-592
PubMed ID: 27814490
DOI: 10.1016/j.molcel.2016.10.011
|
17841
Marchand C, Abdelmalak M, Kankanala J, Huang SY, Kiselev E, Fesen K, Kurahashi K, Sasanuma H, Takeda S, Aihara H, Wang Z, Pommier Y.
Deazaflavin Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) Specific for the Human Enzyme and Active against Cellular TDP2
ACS Chem Biol
2016
11(7):1925-33
PubMed ID: 27128689
DOI: 10.1021/acschembio.5b01047
|
279
Skopek TR, Liber HL, Penman BW, Thilly WG.
Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay
Biochem Biophys Res Commun
1978
84(2):411-6
PubMed ID: 214074
DOI: 10.1016/0006-291x(78)90185-7
|
281
Levy JA, Buell DN, Creech C, Hirshaut Y, Silverberg H.
Further characterization of the WI-L1 and WI-L2 lymphoblastoid lines
J Natl Cancer Inst
1971
46(3):647-54
PubMed ID: 4323138
|
280
Levy JA, Virolainen M, Defendi V.
Human lymphoblastoid lines from lymph node and spleen
Cancer
1968
22(3):517-24
PubMed ID: 5673231
DOI: 10.1002/1097-0142(196809)22:3<517::aid-cncr2820220305>3.0.co;2-a
|